XML 20 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 59,219 $ 39,084
Accounts receivable 8,756 3,503
Supplies inventory 3,475 3,767
Prepaid expenses and other current assets 2,057 1,442
Restricted cash 120 118
Total current assets 73,627 47,914
Property and equipment, net 11,480 10,314
Finite-lived intangible assets, net 14,133 15,200
Goodwill 1,057 1,057
Restricted cash 603 603
Other assets 134 159
Total assets 101,034 75,247
Current liabilities:    
Accounts payable 2,424 5,085
Accrued liabilities 9,110 8,689
Deferred Genzyme co-promotion fee 0 948
Total current liabilities 11,534 14,722
Long-term debt 24,918 4,990
Capital lease liability, net of current portion 599 0
Deferred rent, net of current portion 4,402 4,283
Total liabilities 41,453 23,995
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of December 31, 2016 and 2015 0 0
Common stock, $0.001 par value; 125,000,000 shares authorized, 33,762,278 and 27,685,291 shares issued and outstanding as of December 31, 2016 and 2015, respectively 34 28
Additional paid-in capital 239,631 199,950
Accumulated deficit (180,084) (148,726)
Total stockholders' equity 59,581 51,252
Total liabilities and stockholders' equity $ 101,034 $ 75,247